A Study to Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid Tumors
The primary purpose of this open-label study is to investigate the interaction of ketoconazole, a liver enzyme inhibitor, on oral LBH589 in adult patients with advanced solid tumors. The extension phase of the study will evaluate the safety and efficacy of LBH589 in patients with advanced solid tumors.
Non-Hodgkin Lymphoma|Neoplasms
DRUG: LBH589
Levels of LBH589 in the blood on days 1, 5, 8, 9 and 10 of first cycle, 2 weeks
Safety, tolerability and efficacy of oral LBH589 throughout the study, at least every 2 months
The primary purpose of this open-label study is to investigate the interaction of ketoconazole, a liver enzyme inhibitor, on oral LBH589 in adult patients with advanced solid tumors. The extension phase of the study will evaluate the safety and efficacy of LBH589 in patients with advanced solid tumors.